Out-Of-Pocket Spending And Medication Adherence Among Dialysis Patients In Twelve Countries
- 1 January 2008
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 27 (1) , 89-102
- https://doi.org/10.1377/hlthaff.27.1.89
Abstract
Few studies have examined drug costs and adherence in similar patient cohorts across countries. Using representative samples of hemodialysis patients from twelve countries, we examined out-of-pocket medication spending and cost-related nonadherence. Mean monthly spending ranged from $8 in the United Kingdom to $114 in the United States. The proportion of patients reporting nonadherence because of cost ranged from 3 percent in Japan to 29 percent in the United States. Out-of-pocket spending was related to national pharmaceutical financing policies and predicted national nonadherence rates. However, inconsistencies in the relationship between patient costs and nonadherence suggested that other social or policy factors also matter.Keywords
This publication has 10 references indexed in Scilit:
- A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressuresSocial Science & Medicine, 2005
- Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with DiabetesAnnals of Internal Medicine, 2005
- The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodologyAmerican Journal of Kidney Diseases, 2004
- Cost-Related Medication Underuse Among Chronically III Adults: the Treatments People Forgo, How Often, and Who Is at RiskAmerican Journal of Public Health, 2004
- Three-Tiered–Copayment Drug Coverage and Use of Nonsteroidal Anti-inflammatory DrugsArchives of internal medicine (1960), 2004
- Japan’s Health Care System: Containing Costs And Attempting ReformHealth Affairs, 2004
- International Differences in Drug PricesAnnual Review of Public Health, 2004
- Tracking Health Care Costs: Trends Turn Downward In 2003Health Affairs, 2004
- Prices And Availability Of Pharmaceuticals: Evidence From Nine CountriesHealth Affairs, 2003
- The cost of prescription medicines to patientsHealth Policy, 2000